This article is part of the supplement: Fifth Dominique Dormont International Conference. Host-Pathogen Interactions in Chronic Infections
Lecture presentation
Pharmacological issues in antiretroviral therapy during pregnancy: a clinician's perspective
Retrovirology 2009, 6(Suppl 1):L5 doi:10.1186/1742-4690-6-S1-L5
Published: 22 July 2009First paragraph (this article has no abstract)
All antiretroviral drugs are eventually used in pregnant women, either as prevention of mother-to-child transmission (PMTCT), or as long-term therapy for the woman's own health. Yet, pregnancy data is lacking for recent drugs. Four types of pharmacologic issues should be addressed: